295 related articles for article (PubMed ID: 34841632)
1. Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era.
Park H; Yoon EL; Kim M; Lee J; Kim JH; Cho S; Jun DW; Nah EH
Hepatol Res; 2022 Mar; 52(3):247-254. PubMed ID: 34841632
[TBL] [Abstract][Full Text] [Related]
2. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.
Wu YL; Kumar R; Wang MF; Singh M; Huang JF; Zhu YY; Lin S
World J Gastroenterol; 2021 Sep; 27(34):5753-5763. PubMed ID: 34629799
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population.
Park H; Yoon EL; Kim M; Lee J; Cho S; Jun DW; Nah EH
Front Med (Lausanne); 2022; 9():1024836. PubMed ID: 36405611
[TBL] [Abstract][Full Text] [Related]
4. Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease.
Chen X; Goh GB; Huang J; Wu Y; Wang M; Kumar R; Lin S; Zhu Y
J Clin Transl Hepatol; 2022 Aug; 10(4):589-594. PubMed ID: 36062270
[TBL] [Abstract][Full Text] [Related]
5. Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis.
Huang CF; Liang PC; Wang CW; Jang TY; Hsu PY; Tsai PC; Wei YJ; Yeh ML; Hsieh MY; Lin YH; Huang CK; Dai CY; Huang JF; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2024 Apr; 40(4):374-383. PubMed ID: 38234005
[TBL] [Abstract][Full Text] [Related]
6. A comparison of magnetic resonance elastography (MRE) to biomarker testing for staging fibrosis in non-alcoholic fatty liver disease (NAFLD).
Kaplan JM; Alexis J; Grimaldi G; Islam M; Izard SM; Lee TP
Transl Gastroenterol Hepatol; 2023; 8():7. PubMed ID: 36704653
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Noninvasive Tests in Patients with MetALD in a Health Check-up Cohort.
Oh JH; Ahn SB; Cho S; Nah EH; Yoon EL; Jun DW
J Hepatol; 2024 Jun; ():. PubMed ID: 38879175
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of the fibrosis-4 index and the NAFLD fibrosis score for screening at-risk individuals in a health check-up setting.
Park H; Yoon EL; Kim M; Lee J; Kim HL; Cho S; Nah EH; Jun DW
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37738414
[TBL] [Abstract][Full Text] [Related]
9. New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD.
Torres L; Schuch A; Longo L; Valentini BB; Galvão GS; Luchese E; Pinzon C; Bartels R; Álvares-da-Silva MR
Ann Hepatol; 2023; 28(1):100774. PubMed ID: 36280013
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease.
Park H; Yoon EL; Ito T; Jo AJ; Kim M; Lee J; Kim HL; Arai T; Atsukawa M; Kawanaka M; Toyoda H; Ishigami M; Yu ML; Jun DW; Nguyen MH
JAMA Netw Open; 2023 Aug; 6(8):e2329568. PubMed ID: 37589973
[TBL] [Abstract][Full Text] [Related]
11. Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
Lu C; Chen Y; Zhang Y; Zhao X
Diabetes Metab Syndr Obes; 2023; 16():2627-2637. PubMed ID: 37663203
[TBL] [Abstract][Full Text] [Related]
12. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
13. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.
Cheng YM; Wang CC; Kao JH
Hepatol Int; 2023 Apr; 17(2):350-356. PubMed ID: 36471232
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performances of Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction-associated steatotic liver disease in Asian primary care clinics.
Park H; Kim M; Kim HL; Cho S; Yoon EL; Jun DW
Hepatol Res; 2024 May; ():. PubMed ID: 38703383
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals.
Eren F; Kaya E; Yilmaz Y
Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):98-103. PubMed ID: 32976186
[TBL] [Abstract][Full Text] [Related]
16. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
17. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
McPherson S; Hardy T; Dufour JF; Petta S; Romero-Gomez M; Allison M; Oliveira CP; Francque S; Van Gaal L; Schattenberg JM; Tiniakos D; Burt A; Bugianesi E; Ratziu V; Day CP; Anstee QM
Am J Gastroenterol; 2017 May; 112(5):740-751. PubMed ID: 27725647
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population.
Zambrano-Huailla R; Guedes L; Stefano JT; de Souza AAA; Marciano S; Yvamoto E; Michalczuk MT; Vanni DS; Rodriguez H; Carrilho FJ; Alvares-da-Silva MR; Gadano A; Arrese M; Miranda AL; Oliveira CP
Ann Hepatol; 2020; 19(6):622-626. PubMed ID: 32919087
[TBL] [Abstract][Full Text] [Related]
19. Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes.
Lim TS; Chun HS; Kim SS; Kim JK; Lee M; Cho HJ; Kim SU; Cheong JY
Gut Liver; 2023 Jul; 17(4):610-619. PubMed ID: 36799062
[TBL] [Abstract][Full Text] [Related]
20. A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease.
Mathew JF; Panackel C; Jacob M; Ramesh G; John N
J Clin Exp Hepatol; 2024; 14(5):101407. PubMed ID: 38699513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]